COST-EFFECTIVENESS OF RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINATION OF DUTCH ELDERLY

被引：0
|
作者：
Pouwels, K. [1 ]
Meijboom, M. [1 ]
Luytjes, W. [2 ]
Hak, E. [1 ]
Postma, M. [1 ]
机构：
[1] Univ Groningen, Groningen, Netherlands
[2] Natl Inst Publ Hlth & Environm RIVM, Utrecht, Netherlands
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 07期
关键词：
D O I：
10.1016/j.jval.2011.08.221
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A271 / A271
页数：1
相关论文
共 50 条
  • [1] The cost-effectiveness of a hypothetical respiratory syncytial virus vaccine in the elderly
    Gessner, BD
    [J]. VACCINE, 2000, 18 (15) : 1485 - 1494
  • [2] Pricey or priceless: cost-effectiveness of respiratory syncytial virus (RSV) prevention in infants
    Li, Xiao
    Bilcke, Joke
    Beutels, Philippe
    [J]. LANCET REGIONAL HEALTH-AMERICAS, 2024, 29
  • [3] A COST-EFFECTIVENESS ANALYSIS OF RESPIRATORY SYNCYTIAL VIRUS (RSV) PROPHYLAXIS IN INFANTS IN THE UK
    Bentley, A.
    Filipovic, I.
    Gooch, K.
    Buesch, K.
    [J]. THORAX, 2011, 66 : A136 - A137
  • [4] A SYSTEMATIC REVIEW OF EFFECTIVENESS AND COST-EFFECTIVENESS STUDIES OF VACCINATION FOR RESPIRATORY SYNCYTIAL VIRUS
    Chung, Grace
    Doan, Tran
    Hutton, David W.
    [J]. MEDICAL DECISION MAKING, 2020, 40 (05) : E408 - E409
  • [5] Cost-effectiveness of respiratory syncytial virus (RSV) prophylaxis among preterm infants in Poland
    Kowalik, E
    Jakubczyk, MK
    Niewada, MP
    Kamiñski, B
    [J]. VALUE IN HEALTH, 2003, 6 (06) : 758 - 759
  • [6] A cost-effectiveness analysis of respiratory syncytial virus (RSV) prophylaxis in infants in the United Kingdom
    Bentley A.
    Filipovic I.
    Gooch K.
    Büsch K.
    [J]. Health Economics Review, 3 (1) : 1 - 12
  • [7] COST-EFFECTIVENESS OF PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS INFECTION (RSV) WITH PALIVIZUMAB IN PRETERM INFANTS IN COLOMBIA
    Rosselli, D.
    Rueda, J. D.
    Ruiz, J. G.
    [J]. VALUE IN HEALTH, 2013, 16 (03) : A75 - A75
  • [8] COST-EFFECTIVENESS OF RESPIRATORY SYNCYTIAL VIRUS (RSV) PREVENTION INTERVENTIONS IN CHILDREN: A MODEL COMPARISON STUDY
    Li, X. X.
    Hodgson, D.
    Flaig, J.
    Kieffer, A.
    Herring, W.
    Beyhaghi, H.
    Williem, L.
    Jit, M.
    Bilcke, J.
    Beutels, P.
    [J]. VALUE IN HEALTH, 2022, 25 (12) : S178 - S178
  • [9] COST-EFFECTIVENESS OF NIRSEVIMAB AGAINST RESPIRATORY SYNCYTIAL VIRUS (RSV) AMONG US INFANTS EXPERIENCING THEIR FIRST RSV SEASON
    Beuvelet, M.
    Chung-Delgado, K.
    Kieffer, A.
    [J]. VALUE IN HEALTH, 2021, 24 : S110 - S110
  • [10] Cost-effectiveness of potential infant vaccination against respiratory syncytial virus infection in The Netherlands
    Meijboom, M. J.
    Rozenbaum, M. H.
    Benedictus, A.
    Luytjes, W.
    Kneyber, M. C. J.
    Wilschut, J. C.
    Hak, E.
    Postma, M. J.
    [J]. VACCINE, 2012, 30 (31) : 4691 - 4700
12345